Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1997-5-2
pubmed:abstractText
Tumor necrosis factor (TNF) is recognized as a central mediator of sepsis, septic shock, and multiple organ failure. These host reactions are associated with increased TNF levels in circulation, presumably due to increased TNF production. A previously described nucleotide variation at position -308 in the promoter region of the human TNF gene was shown to be associated with the clinical outcome of malaria. In this study we addressed the relevance of the -308 polymorphism for expression of the human TNF gene in response to bacterial endo- toxin in vivo and in vitro. First, we typed 80 patients suffering from severe sepsis and 153 healthy individuals and found no association of the -308 variation with incidence of the disease. In contrast, the NcoI marker in the closely linked lymphotoxin-alpha (LT-alpha) gene showed association with survivaL This discrepancy can be explained by the linkage of the TNFB2(NcoI) allele to the common TNF1 (-308) allele. Second, we generated reporter gene constructs with the promoter deletions and with both -308 variation in the context of the extended human TNF promoter region. Although such constructs were highly inducible by lipopolysaccharide (LPS) in transient transfections into a macrophage cell line, the -308 variation had no significant effect on transcription, consistent with the promoter deletion study. We conclude that the functional consequence of the -308 polymorphism may be unrelated to transcriptional response of the TNF gene to bacterial endotoxin.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1078-7852
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
42-50
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:8832971-Adult, pubmed-meshheading:8832971-Aged, pubmed-meshheading:8832971-Alleles, pubmed-meshheading:8832971-Animals, pubmed-meshheading:8832971-Cell Line, pubmed-meshheading:8832971-Deoxyribonucleases, Type II Site-Specific, pubmed-meshheading:8832971-Gene Deletion, pubmed-meshheading:8832971-Heterozygote, pubmed-meshheading:8832971-Homozygote, pubmed-meshheading:8832971-Humans, pubmed-meshheading:8832971-Lipopolysaccharides, pubmed-meshheading:8832971-Mice, pubmed-meshheading:8832971-Middle Aged, pubmed-meshheading:8832971-Mutagenesis, Site-Directed, pubmed-meshheading:8832971-Polymorphism, Genetic, pubmed-meshheading:8832971-Promoter Regions, Genetic, pubmed-meshheading:8832971-Sepsis, pubmed-meshheading:8832971-Survival Rate, pubmed-meshheading:8832971-Tumor Necrosis Factor-alpha
pubmed:articleTitle
-308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter.
pubmed:affiliation
Clinic for Anesthesiology and Intensive Care Medicine, Christian-Albrechts-University, Kiel, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't